Embody vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi beats Embody overall, scoring 7.7/10 vs 7.3/10. Embody is more affordable at $149/mo vs $179/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll choose t. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at Embody and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Embody

#37 of 52

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Embody	MEDVi
Our Score	7.3/10	7.7/10
Starting Price	$149/mo	$179/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	People who want the oral tirzepatide gum, or who'll choose the $299/mo 'Embody Flat' plan at signup for one predictable price	Users who want a low entry price with oral and injectable compounded options
Ranking	#37	#20
Get started	Visit Embody	Visit MEDVi

Pros & Cons Compared

Embody

Pros

+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
+'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299–$399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
−Trustpilot rating is a polarized 3.3 / 5 across 46 reviews: 41% five-star, 24% one-star. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
−Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

MEDVi edges out Embody with a score of 7.7/10 vs 7.3/10. If budget is your priority, Embody starts at $149/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll choose the $299/mo 'embody flat' plan at signup for one predictable price. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Embody nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review